Showing results (1-10 of 255) with videos related to
Sort By:
Pageof 26
European Journal of Pharmacology|March 20, 2012
Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomitingCamilo Rojas, Barbara S SlusherTrends in Pharmacological Sciences|November 27, 2025
Resilient pathways for drug discovery in challenging timesSean Ekins, Barbara S SlusherCancer Treatment Reviews|October 8, 2015
Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron)Camilo Rojas, Barbara S SlusherCurrent Protocols in Pharmacology|October 1, 2011
Measurement of glutamate carboxypeptidase II (NAALADase) enzyme activity by the hydrolysis of [³H]-N-acetylaspartylglutamate (NAAG)Carol W Tiffany, Barbara S SlusherJournal of Medicinal Chemistry|January 4, 2021
Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid NetworkJan Skácel, Barbara S Slusher, Takashi TsukamotoACS Chemical Neuroscience|February 15, 2017
Role of Academic Drug Discovery in the Quest for New CNS TherapeuticsBrian H Yokley, Matthew Hartman, Barbara S SlusherJournal of Biomolecular Screening|August 16, 2013
Inhibition of microglia activation as a phenotypic assay in early drug discoveryMariana Figuera-Losada, Camilo Rojas, Barbara S SlusherDrug Discovery Today|September 11, 2007
Progress in the discovery and development of glutamate carboxypeptidase II inhibitorsTakashi Tsukamoto, Krystyna M Wozniak, Barbara S SlusherACS Chemical Neuroscience|January 18, 2024
Empirical Analysis of Drug Targets for Nervous System DisordersLouis G Mueller, Barbara S Slusher, Takashi TsukamotoThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 26, 2016
Neuromuscular NMDA Receptors Modulate Developmental Synapse EliminationKirkwood E Personius, Barbara S Slusher, Susan B UdinPageof 26